317 A.3d 875
D.C.2024Background
- Barry Stringer, incarcerated for murder and related offenses, moved for compassionate release under D.C.'s statute due to COVID-19 risks.
- Stringer argued his comorbidities (diabetes, obesity, high blood pressure, high cholesterol) made him acutely vulnerable despite being vaccinated.
- The trial court initially found extraordinary risk warranted review but denied release for lack of proof of non-dangerousness; the case was remanded for further findings.
- On remand, after expert testimony from an infectious disease physician, the court found Stringer was not acutely vulnerable, as required for release.
- Stringer appealed, arguing the court failed to recognize his comorbidities as sufficient for acute vulnerability.
- The appellate court affirmed, focusing on the individualized, heightened showing required by precedent for "acute vulnerability" post-vaccination.
Issues
| Issue | Stringer's Argument | U.S. Argument | Held |
|---|---|---|---|
| Definition of "acute vulnerability" | Comorbidities and incarceration make him acutely vulnerable to COVID | Vaccine mitigates risk; generalized risk insufficient | Must show > above-average risk; Stringer did not |
| Effect of vaccination on risk assessment | Comorbidities/age offset vaccine benefit; risk remains acute | Vaccination greatly reduces risk; no proof of reduced efficacy here | Vaccination effective unless individualized evidence shows otherwise |
| Sufficiency of expert testimony | Doctor’s statement on "high risk" meets the standard | Testimony did not show acute vulnerability unique to Stringer | Testimony too general/unquantified for acute vulnerability |
| Individualized risk versus general population | Prison, age, comorbidities elevate his risk compared to others | Risk must be individualized; not everyone with comorbidities qualifies | Individualized, not group, risk governs eligibility |
Key Cases Cited
- Autrey v. United States, 264 A.3d 653 (D.C. 2021) (acute vulnerability under D.C. compassionate release law requires more than above-average risk; individualized showing required)
- Facon v. United States, 288 A.3d 317 (D.C. 2023) (remanded for trial court to assess if risk factors make someone acutely vulnerable post-vaccination)
- Colbert v. United States, 310 A.3d 608 (D.C. 2024) (individualized risk assessment central; age as a factor must be considered in eligibility)